RxDoctor Payments Data

Jawahar Sundaram, MD

Family Medicine · Los Angeles, CANPI 1720082100

Payments from drug & device makers

$46,125in general payments, 2019–2025

Across 27 payments — averaging $1708.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Taro Pharmaceuticals USA, Inc.$46K
  • AbbVie$313
  • Amgen$26
  • Lilly USA, LLC$19
  • Cranial Technologies, Inc$17

What the payments were for

  • Speaking & faculty fees$4512%
  • Food & beverage$33188%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Taro Pharmaceuticals USA, Inc.9$45,750
AbbVie(2 entities)15$313
Amgen1$26
Lilly USA, LLC1$19
Cranial Technologies, Inc1$17

How this compares

$46,125 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$1,203
Medicare patients
25
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →